Recent Updates
Recently added Catalysts
HIT

Health In Tech Announces $7.0 Million Private Placement Stuart, FL.

Key Takeaway: Health In Tech, Inc. has announced a private placement expected to raise approximately $7 million before fees. The funds will be used for expanding sales distribution, advancing technology development, and supporting new product initiatives. The private investment in public equity (PIPE) is set to close by March 27, 2026, contingent upon customary closing conditions. The company has agreed to file a resale registration statement with the SEC to register the resale of shares issued in this placement.

Market Sentiment Analysis

Full Press Release Details

Health In Tech Announces $7.0 Million Private Placement
Stuart, FL., March 25, 2026 /PRNewswire/ - Health In Tech, Inc.
(Nasdaq: HIT) ("Health In Tech" or the "Company"), an AI-enabled InsurTech platform company, today announced that
it has entered into a securities purchase agreement for a private investment in public equity financing (the "PIPE") that
is expected to result in gross proceeds of approximately $7.0 million before deducting placement agent fees and offering expenses. The
PIPE is expected to close on or about March 27, 2026, subject to the satisfaction of customary closing conditions.
Pursuant to the terms of the securities purchase agreement, at the
closing of the PIPE, Health In Tech will issue an aggregate of 5,600,000 shares of common stock at a price of $1.25 per share.
Craig-Hallum Capital Group LLC acted as the sole placement agent for
The Company intends to use the net proceeds from the PIPE to expand
sales distribution, advance technology development, support new product development, and for general corporate purposes and working capital.
The securities described above are being offered in a private placement
under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"), and/or Regulation D promulgated thereunder,
and have not been registered under the Securities Act or applicable state securities laws. Accordingly, the securities issued in the PIPE
may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from
the registration requirements of the Securities Act and such applicable state securities laws. Pursuant to a registration rights agreement
with the PIPE investors, the Company has agreed to file a resale registration statement with the Securities and Exchange Commission registering
the resale of the shares of common stock described above.
This press release shall not constitute an offer to sell or a solicitation
of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such
offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or
Use of Forward-Looking Statements
Certain statements in this press release are forward-looking statements
for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements
may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies
and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking
statements can be identified by terms such as "may," "will," "should," "design," "target,"
"aim," "hope," "expect," "could," "intend," "plan," "anticipate,"
"estimate," "believe," "continue," "predict," "project," "potential," "goal,"
or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's
future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual
results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or
achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements
because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control
and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement
reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions
relating to Health In Tech's operations, results of operations, growth strategy and liquidity. Health In Tech undertakes no obligation
to update any forward-looking statements, except as required by law.
About Health In Tech
Health In Tech, Inc. (Nasdaq: "HIT")
is an AI-enabled InsurTech platform company, which offers a marketplace that improves processes in the health insurance industry through
vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales
and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs) and third-party administrators ("TPAs").
Health In Tech's platform serves as a marketplace for brokers, TPAs, MGUs and carriers to access self-funded health insurance for
employers, providing functions including customized self-funded health plans, bindable stop-loss quotes, AI-enabled underwriting, claims
administration and reporting integration.
Health In Tech Investor Relations
Devin Sullivan, Managing Director

Frequently Asked Questions

What is the amount of Health In Tech's private placement?

Health In Tech announced a private placement totaling $7.0 million.

When is the closing date for the PIPE investment?

The PIPE is expected to close on or about March 27, 2026.

How many shares will be issued in the private placement?

Health In Tech will issue 5,600,000 shares at $1.25 per share.

What will proceeds from the PIPE be used for?

Proceeds will expand sales, advance technology, and support product development.

Is the offered security registered under the Securities Act?

No, the offered securities have not been registered under the Securities Act.

Last updated: Mar 25, 2026